Biotech entity
Every one of those 1 sits in a single category, pharma. Ainos, Inc. is most often covered alongside AI Nose, which appears in 1 of these 1 story. The tracked stories average 3 original sources each. Ainos, Inc. appears in 1 tracked Biotech story from August 4, 2026.
Last mentioned: Aug 4, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Ainos, Inc. is most often covered alongside AI Nose, which appears in 1 of these 1 story. The tracked stories average 3 original sources each. Ainos, Inc. appears in 1 tracked Biotech story from August 4, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Ainos, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Ainos aims to deploy its AI Nose in pharmaceutical cleanrooms, using a 613-million-record dataset trained largely in semiconductor fabs. The technology could enable continuous contaminant detection, reducing batch loss risks in bioprocessing.
Ainos, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
